Literature DB >> 19583956

Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.

Simon A Pot1, Heather L Chandler, Carmen M H Colitz, Ellison Bentley, Richard R Dubielzig, Thomas S Mosley, Ted W Reid, Christopher J Murphy.   

Abstract

The purpose of this study was to determine the inhibitory effect of selenocystamine coated intraocular lenses (IOLs) on the formation of posterior capsule opacification (PCO) in an ex vivo canine lens capsular bag assay. Selenocystamine was covalently bound to the surface of poly(2-hydroxyethyl methacrylate) (poly(HEMA)) discs. Three groups of canine lens capsules (6 coated IOLs (SeIOLs), 7 non-coated control IOLs and 8 empty capsules) were cultured for 10 days. During the culture period PCO was scored based on visual inspection of the capsules using phase contrast microscopy. On day 10 all the capsules were prepared for light microscopic examination and lens epithelial cells (LECs) were quantified. Proliferating cell nuclear antigen (PCNA), alpha-smooth muscle actin (alpha-SMA) and cleaved caspase-3 were examined by immunohistochemistry. Additionally, cell viability assays were performed on LECs cultured in tissue culture medium pre-incubated with either a SeIOL or control IOL. The viability assays demonstrated that no detectable cytotoxic leachables were associated with the functionalized IOLs. The central posterior capsule was free of cells underneath all SeIOLs, although large numbers of LECs populated the capsular periphery. Apoptotic cells were observed underneath the periphery of some SeIOLs. Both the PCO scores and LEC counts of SeIOL containing capsules were significantly lower than those of control group capsules (p < 0.01 and p = 0.0004, respectively). The use of selenium functionalized IOLs resulted in a significant reduction of PCO in this ex vivo model. Binding of selenocystamine to a foldable IOL may provide an effective method to prevent population of the central posterior capsule with LECs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19583956     DOI: 10.1016/j.exer.2009.06.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

1.  Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity.

Authors:  Jennifer L Davis; Na Young Yi; Jacklyn H Salmon; Anna N Charlton; Carmen M H Colitz; Brian C Gilger
Journal:  J Ocul Pharmacol Ther       Date:  2012-02-28       Impact factor: 2.671

2.  The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.

Authors:  Heather L Chandler; Terah R Webb; Curtis A Barden; Mirunalni Thangavelu; Samuel K Kulp; Ching-Shih Chen; Carmen M H Colitz
Journal:  Mol Vis       Date:  2010-10-29       Impact factor: 2.367

Review 3.  Drug-Eluting Intraocular Lenses.

Authors:  Clara González-Chomón; Angel Concheiro; Carmen Alvarez-Lorenzo
Journal:  Materials (Basel)       Date:  2011-11-01       Impact factor: 3.623

4.  In vitro assessment of the biocompatibility of chemically treated silicone materials with human lens epithelial cells.

Authors:  Elizabeth C Y Kao; Junghee Seo; David J McCanna; Lakshman N Subbaraman; Lyndon W Jones
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

Review 5.  Posterior Capsule Opacification: A Review of Experimental Studies.

Authors:  Joanna Konopińska; Maryla Młynarczyk; Diana Anna Dmuchowska; Iwona Obuchowska
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

Review 6.  Factors Affecting Posterior Capsule Opacification in the Development of Intraocular Lens Materials.

Authors:  Grace Cooksley; Joseph Lacey; Marcus K Dymond; Susan Sandeman
Journal:  Pharmaceutics       Date:  2021-06-10       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.